U.S. Food and Drug Administration Archives

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

SILVER SPRING, Md., May 12, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to...

News19 hours ago

La FDA aprueba el primer medicamento para tratar los síntomas de agitación asociados con la demencia debida a la enfermedad de Alzheimer

In English SILVER SPRING, Md., 11 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por...

News19 hours ago

La FDA finaliza la transición para recomendar una evaluación de riesgos individual a fin de determinar la elegibilidad para donaciones de sangre

In English SILVER SPRING, Md., 11 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por...

News1 day ago

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease

SILVER SPRING, Md., May 11, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment...

News1 day ago

FDA Finalizes Move to Recommend Individual Risk Assessment to Determine Eligibility for Blood Donations

SILVER SPRING, Md., May 11, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration finalized recommendations for assessing blood donor eligibility using a set of...

Stark County News

All posts tagged "U.S. Food and Drug Administration"

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

La FDA aprueba el primer medicamento para tratar los síntomas de agitación asociados con la demencia debida a la enfermedad de Alzheimer

La FDA finaliza la transición para recomendar una evaluación de riesgos individual a fin de determinar la elegibilidad para donaciones de sangre

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease

FDA Finalizes Move to Recommend Individual Risk Assessment to Determine Eligibility for Blood Donations

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

Increasing Demand from End-use Industries Post COVID-19 Pandemic Bolsters Growth

Ergebnisse der klinischen Phase-I-Studie mit dem bifunktionalen PD-1/CTLA-4-Antikörper Iparomlimab/Tuvonralimab von Qilu Pharma wurden online im Journal of Hematology & Oncology veröffentlicht USA – Deutsch APAC – English USA – English USA – español

Alan Thicke’s Intriguing Contribution To Juvenile Diabetes, Because His Legacy Lives On

Prevention And Treatment Of Opportunistic Infections In HIV

RSV Experimental Vaccine For Children- Risks And Consequences

The final 6 ‘Game of Thrones’ episodes might feel like a full season

New Season 8 Walking Dead trailer flashes forward in time

Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens